Clinical Trial

Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.

Study acronym: ISoPECC
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Sarcopenia's role in early-onset colorectal cancer (EOCRC), a subtype increasingly diagnosed in individuals under 50 years, has not yet been investigated according to recent literature. Understanding the prevalence and prognostic impact of sarcopenia in EOCRC could inform tailored therapeutic approaches and improve patient outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-05.
Trial Details
NCT Number NCT06868095
Lead Sponsor Instituto de Investigación Biomédica de Salamanca
Conditions Colorectal Cancer, Early Onset Colorectal Cancer, Sarcopenia, Prognostic Factors, Overall Survival, Disease-free Survival
Enrollment 1,000 participants
Start Date 2000-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-12